Evaulation of Bone Mineral Density in Type II Diabetic
PDF
Cite
Share
Request
Original Article
P: 23-24
December 2004

Evaulation of Bone Mineral Density in Type II Diabetic

İstanbul Med J 2004;5(4):23-24
1. Bakırköy Dr. Sadi Konuk Eğitim Araştırma Hastanesi, Tıbbi Onkoloji Bilim Dalı, İstanbul, Türkiye
2. Department of Internal Medicine and Hematology, Bezmialem Vakıf University Faculty of Medicine, İstanbul, Türkiye
3. SB İstanbul Eğitim Ve Araştırma Hastanesi 1. Dahiliye Kliniği
No information available.
No information available
PDF
Cite
Share
Request

ABSTRACT

Objectives:

In Type II Diabetics, the BMD was investigated and compared with nondiabetics.

Patients and Methods:

The study was included 52 type II diabetics (39 women and 13 men; mean age 54.96±12.05 years, mean BMI (Body Mass Index) 34.3±4.8) and 24 Nondiabetics (16 women and 8 men; mean age 55.11±11.86 years, mem BMI 31.8±5.7) as control group. In study group, diabetic mean age was 9.2±7.8 years and mean HbA1C (glicolyzated hemoglobin) level was %7.83±1.8 %. Bone mineral density estimations were obtained via DEXA* method from L1 - L4 (Lomber) vertebras and collum femoris. BMI was obtained acording to formulation (weight (kg) ÷ height2 (m). DEXA: Dual Energy X-Ray Absorptiometry.

Results:

There was not statistically signifinance between two groups about age, gender and BMI (p>0.05) (Table I), but BMD of study group was statistically low compared with control group (p<0.05) (Table II).

Conclusion:

In Type II diabetics, the BMD is statistically low comparing the normal population. For this reason, monitorizing and well treatment of this patient group is very important for avoidance of complications and morbidity.

Keywords:
Type II Diabetics, Bone Mineral Density (BMD), Body Mass Index (BMI), Dual Energy X-Ray Absorptiometry (DEXA)